Telomeres in lung diseases.

Area of Science:

• Genetics and Molecular Biology
• Pulmonology
• Cellular Biology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease.
• Genetic factors, including mutations in telomerase genes (TERT, TERC) and short telomeres, are established risk factors for IPF.
• Short telomeres are also associated with other conditions like dyskeratosis congenita and pulmonary fibrosis with emphysema syndrome.

Purpose of the Study:

• To explore the role of telomere length and telomerase mutations in the pathogenesis of idiopathic pulmonary fibrosis.
• To investigate the prevalence of telomerase gene mutations in familial and sporadic IPF cases.
• To highlight the need for further research into the unclear disease mechanisms of IPF.

Main Methods:

• Analysis of telomerase gene mutations (TERT, TERC) in patients with familial and sporadic IPF.
• Assessment of telomere length in patients with IPF.
• Review of existing literature linking telomere dysfunction to pulmonary fibrosis.

Main Results:

• Heterozygous mutations in TERT or TERC are found in up to 15% of familial and 5% of sporadic IPF cases.
• Cells from patients with these mutations retain approximately 50% of telomerase activity.
• Short telomeres are a common feature in most IPF patients, even without identified telomerase mutations.

Conclusions:

• Short telomeres are a significant factor in idiopathic pulmonary fibrosis development.
• While telomerase mutations are implicated, they do not account for all cases.
• The precise molecular mechanisms by which short telomeres lead to IPF remain to be elucidated.